LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER
Compound with spectra: 1 NMR
![LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER](/api/compound/GycvbGY19hv.png?ph=true&h=300&w=458 "LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER")
| SpectraBase Compound ID | GycvbGY19hv |
|---|---|
| InChI | InChI=1S/C25H26O6/c1-28-24(25(26)27)18-19-8-10-20(11-9-19)29-16-5-17-30-21-12-14-23(15-13-21)31-22-6-3-2-4-7-22/h2-4,6-15,24H,5,16-18H2,1H3,(H,26,27)/t24-/m0/s1 |
| InChIKey | OKJHGOPITGTTIM-DEOSSOPVSA-N |
| Mol Weight | 422.48 g/mol |
| Molecular Formula | C25H26O6 |
| Exact Mass | 422.172939 g/mol |
| Enantiomer InChIKey | OKJHGOPITGTTIM-XMMPIXPASA-N |
| Racemate InChIKey | OKJHGOPITGTTIM-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
2-(4-phenoxyphenoxy)ethyl 4-methylbenzenesulfonate
2-Amino-3-(4-benzyloxyphenyl)propionic acid, t-butyl ester
2-acetamido-3-[4-(3-methylbut-2-enoxy)phenyl]propionic acid
Morpholine, 2,6-dimethyl-4-[2-methyl-3-(4-phenoxyphenyl)propyl]-
4-(1,1-DIFLUORO-2-CHLORO-2-BROMOETHOXY)-L-PHENYLALANINE
1H-1,2,4-Triazole, 1,3-dimethyl-5-[(4-phenoxyphenoxy)methyl]-
3-(p-methoxyphenyl)-2-phenylpropionic acid
Methyl N-[2-[4-[(2-oxidanylidenecyclohexyl)methyl]phenoxy]ethyl]carbamate
Dimethyl[4-(p-methoxyphenoxy)phenyl]-malonate
4-(3-Bromophenoxy)phenoxyethyl Tetrahydro-2H-pyran-2-yl Ether
| Title | Journal or Book | Year |
|---|---|---|
| The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-Activated Receptor α-γ Dual, γ-Dominant Agonist in Mice, Rats, and Monkeys | Drug Metabolism and Disposition | 2006 |